1|0|Public
50|$|<b>Hydroxystenozole</b> (INN), {{also known}} as 17α-methylandrost-4-eno3,2-cpyrazol-17β-ol, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated {{derivative}} of testosterone that was described in the literature in 1967 but was never marketed. It {{is closely related to}} stanozolol (17α-methyl-5α-androstano3,2-cpyrazol-17β-ol), differing from it only in hydrogenation (i.e., double bonds and their placement).|$|E

